Developed in France, a micro robot smaller than a grain of rice promises to intervene in the heart of the brain with unprecedented precision. Its objective: to treat serious illnesses while limiting damage to healthy tissues.
At first glance, it doesn’t look like much. A few millimeters long, barely wider than a grain of rice, this cylindrical object was nevertheless designed to venture into the most complex organ of the human body. Its ambition is immense: to intervene directly in the brain to treat serious pathologies, such as certain tumors, with minimal impact on healthy areas.
Behind this innovation is the French start-up Robeauté, founded in 2017. Based in Paris, the company has been working for several years on this micro robot capable of moving inside brain tissue. Unlike traditional surgical instruments, which require a relatively wide opening of the skull and pass through the tissues in a straight line, this device is designed to progress in depth while limiting trauma.
The principle is based on a unique mechanical approach. The micro robot advances by rotating on itself, a bit like a tiny screw making its way through matter. This controlled rotation allows it to gently move cells rather than brutally sever them. Result: fewer lesions and a reduced risk of complications. Guided by medical imaging, it can be directed to a specific area, for example to the heart of a tumor that is difficult to access.
Brain surgery remains one of the most delicate areas of medicine today. The brain concentrates billions of neurons and every millimeter counts. An intervention that is too invasive can cause motor, sensory or cognitive after-effects. This is where the micro robot could be a game changer. By accessing deep regions without widely opening the skull or passing through large volumes of tissue, it would offer a more targeted alternative.
The first targeted applications concern in particular the treatment of brain tumors. The device could take samples to refine a diagnosis or directly deliver a drug inside the tumor mass. This local administration would increase the concentration of treatment where it is needed, while reducing side effects for the rest of the body. Ultimately, other neurological diseases could be affected, such as certain forms of epilepsy or neurodegenerative diseases.
The project has already attracted investors. The young company has raised several million euros to finance the development of its device and prepare for clinical trials. The regulatory steps remain numerous: before any large-scale use, the micro robot will have to prove its safety and effectiveness during rigorous studies. The first preclinical tests, however, showed results that the team considered encouraging.
This type of innovation is part of a broader trend: the miniaturization of medical tools and the rise of robotics in the operating room. Systems like the Da Vinci surgical robot have already transformed certain procedures. Robeauté’s project pushes the logic even further, on a microscopic scale, directly into the tissues.
If clinical trials confirm current promises, this micro robot could open a new era for neurosurgery. Less invasive, more precise, these targeted interventions would offer new options to patients for whom solutions are currently limited. Between technological prowess and medical hope, this tiny device raises considerable stakes.
